ストックスクリーナーアプリを入手
310.86
1.40%
-4.42
アフターアワーズ：
310.86
前日終値:
$315.28
開ける：
$314.98
24時間の取引高:
1.16M
Relative Volume:
0.66
時価総額：
$83.04B
収益：
$254.47B
当期純損益:
$5.03B
株価収益率:
17.21
EPS:
18.06
ネットキャッシュフロー:
$6.01B
1週間 パフォーマンス:
-1.96%
1か月 パフォーマンス:
-7.16%
6か月 パフォーマンス:
-7.62%
1年 パフォーマンス:
-6.71%
1日の値動き範囲:
$310.29
$315.80
1週間の範囲:
$310.20
$316.99
52週間の値動き範囲:
$262.03
$370.82
Cigna Group Stock (CI) Company Profile
CI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
310.86 | 84.71B | 254.47B | 5.03B | 6.01B | 18.06 |
|
UNH
Unitedhealth Group Inc
|
298.11 | 274.85B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
377.95 | 90.40B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CVS
Cvs Health Corp
|
62.45 | 78.57B | 378.96B | 5.28B | 5.94B | 4.19 |
|
CNC
Centene Corp
|
55.93 | 30.22B | 163.07B | 3.31B | -490.00M | 6.24 |
Cigna Group Stock (CI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-06 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Piper Sandler | Overweight |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-06 | 開始されました | Barclays | Overweight |
| 2024-02-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-01-04 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-18 | ダウングレード | Edward Jones | Buy → Hold |
| 2023-06-06 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Neutral |
| 2023-04-05 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | 再開されました | Morgan Stanley | Overweight |
| 2022-11-21 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | ダウングレード | Jefferies | Buy → Hold |
| 2022-06-22 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | 開始されました | Loop Capital | Hold |
| 2022-05-27 | 再開されました | Bernstein | Mkt Perform |
| 2022-05-26 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-05-16 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-05-09 | アップグレード | Cowen | Market Perform → Outperform |
| 2022-02-07 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-01-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-12-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | 開始されました | Goldman | Neutral |
| 2021-11-17 | 開始されました | Seaport Research Partners | Buy |
| 2021-09-27 | 開始されました | SVB Leerink | Mkt Perform |
| 2021-09-10 | ダウングレード | BofA Securities | Buy → Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-06 | 繰り返されました | BofA Securities | Buy |
| 2021-08-06 | 繰り返されました | Citigroup | Buy |
| 2021-08-06 | 繰り返されました | Deutsche Bank | Buy |
| 2021-08-06 | 繰り返されました | Jefferies | Buy |
| 2021-08-06 | 繰り返されました | Mizuho | Buy |
| 2021-08-06 | 繰り返されました | Oppenheimer | Outperform |
| 2021-08-06 | 繰り返されました | Truist | Buy |
| 2021-05-19 | 開始されました | Wells Fargo | Equal Weight |
| 2020-07-01 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-05-04 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | ダウングレード | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | 開始されました | Mizuho | Buy |
| 2019-09-30 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Buy |
| 2019-08-06 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | 開始されました | UBS | Buy |
| 2019-01-14 | 開始されました | Stephens | Overweight |
| 2018-12-24 | 開始されました | Edward Jones | Buy |
| 2018-03-13 | 開始されました | Bernstein | Mkt Perform |
| 2018-03-08 | 開始されました | Barclays | Overweight |
| 2018-01-03 | 開始されました | Goldman | Neutral |
| 2017-11-03 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-06-22 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-06-12 | 開始されました | Credit Suisse | Outperform |
| 2017-06-07 | 開始されました | Morgan Stanley | Overweight |
| 2017-05-08 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-04-05 | 開始されました | Deutsche Bank | Buy |
すべてを表示
Cigna Group (CI) 最新ニュース
CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now? - TradingView
The Zacks Analyst Blog Highlights Costco Wholesale, Chubb, Cigna, Global Self Storage and Natural Health Trends - Yahoo Finance
Cigna’s SWOT analysis: stock poised for growth amid healthcare challenges - Investing.com
UBS Maintains Buy Rating on Cigna (CI) Stock - Insider Monkey
Molson Coors and Cigna Head My “Do Nothing” Stock List - TribLIVE.com
UBS maintains Cigna stock Buy rating with $390 target - Investing.com
Top Research Reports for Costco, Chubb & Cigna - Yahoo Finance
Guggenheim Reiterates Buy Rating for Cigna Group (CI) with $388 Price Target | CI Stock News - GuruFocus
Cigna Adds Kerecis Intact Fish-Skin Grafts to Coverage Policy - Business Wire
Cigna's (CI) Evernorth Secures Open Access for Key Products | CI Stock News - GuruFocus
Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo Nordisk Weight Loss Drugs - MSN
FTC Scraps PepsiCo Price Discrimination Case In 3-0 Vote, Marking Major Shift As Trump-Era Leadership Reverses Biden CrackdownCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Cigna is putting a cap on weight loss drug costs - Yahoo Finance
Cigna (CI) Caps Out-of-Pocket Costs on Weight-Loss Drugs for Pat - GuruFocus
Cigna (CI) Caps Out-of-Pocket Costs on Weight-Loss Drugs for Patients | CI Stock News - GuruFocus
Cigna (CI) Expands Access to Weight Loss Medications with New Ph - GuruFocus
Cigna (CI) Unit Launches Cost-Effective Pharmacy Benefit for Wei - GuruFocus
Cigna (CI) Launches Cost-Effective Benefit Option for Weight Loss Drugs | CI Stock News - GuruFocus
Cigna (CI) Caps Weight-Loss Drug Costs, Impact on Telehealth Offerings | CI Stock News - GuruFocus
Former employees sue Cigna's 401(k) fiduciaries for misusing forfeited employer match money - Pensions & Investments
Pharmalittle: We're reading about rising drug prices, Cigna's plan for weight loss drugs, and more - statnews.com
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit - Reuters
Cigna (CI) Launches Cost-Capping Program for Weight-Loss Drugs - GuruFocus
Cigna’s Evernorth caps weight-loss drug copays at $200/month (CI:NYSE) - Seeking Alpha
Cigna Offers New Weight-Loss Drug Pricing Plan to Boost Use - Bloomberg.com
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs - MSN
Cigna (CI) Faces Increased Scrutiny Amid Expanded Medicare Audits | CI Stock News - GuruFocus
Cigna Group's Evernorth Launches Benefit Option to Lower Weight Loss Medicine Costs - marketscreener.com
Cigna (CI) Affected by Medicare Advantage Audit Expansion | CI Stock News - GuruFocus
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month - Quantisnow
Cigna Accused of Misusing Retirement Plan Funds - USA Herald
Baird Adjusts Price Target on Cigna Group to $364 From $362, Maintains Outperform Rating - marketscreener.com
Cigna Accused Of Mismanaging Retirement Plan Funds - Law360
2nd Circ. Affirms Dismissal Of Lab's Payment Suit Against Cigna - Law360
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years - Benzinga
Cigna Group (CI) Reaffirms 2025 Financial Outlook - GuruFocus
Cigna Reaffirms 2025 Earnings Projection Amid Investor Meetings - TipRanks
Virtual-Care Company Omada Files IPO Papers - Healthcare Innovation
Forfeiture Lawsuit Filed Against Cigna; Intuit Reaches Settlement - planadviser
Cigna employees file a 401(k) lawsuit, alleging misuse of forfeited funds - BenefitsPRO
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
The Cigna Group Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Cigna Hit With Forfeiture Lawsuit; Intuit Reaches Settlement - plansponsor
Trump’s Drug Pricing Order Targets PBMs—Pharma Stocks May Escape the Worst - Investing.com
CI Q1 Earnings Call: Cigna Delivers Revenue Beat and Focuses on Healthcare Innovation - Yahoo Finance
Exclusive | UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud - WSJ
Cigna (CI) Loses Oncology Leader to The Oncology Institute | CI Stock News - GuruFocus
Aetna, Cigna Can't Nix Suit Over Late Emergency Benefit Bills - Law360
Why We Don’t Use Statements: Cigna Criticized After Denying Life-Saving Lung Transplant Before Media Backlash - NBC Palm Springs
Jeff Auxier's Strategic Moves: A Closer Look at The Cigna Group and More - Yahoo Finance
Cigna Group (CI) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
2.98%
大文字化:
|
ボリューム (24 時間):